| Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS) (NCT00407186) | Dutch Colorectal Cancer Group | 2007-01-11 |
| The Efficacy of Serum Pepsinogen for Prediction of Metachronous Gastric Neoplasm (NCT02682446) | Kyungpook National University Hospital | 2007-01-01 |
| CT Body Composition Enhances Survival Risk Stratification (NCT07109271) | Chang Gung Memorial Hospital | 2007-01-01 |
| Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer (NCT00415168) | Eli Lilly and Company | 2006-12-01 |
| Study of XELOX With Cetuximab in Advanced Gastric Cancer (NCT00398398) | Asan Medical Center | 2006-11-01 |
| Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors (NCT00433602) | European Organisation for Research and Treatment of Cancer - EORTC | 2006-11-01 |
| Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer (NCT00537121) | Roswell Park Cancer Institute | 2006-11-01 |
| Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors (NCT00580281) | Memorial Sloan Kettering Cancer Center | 2006-11-01 |
| Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma (NCT00515411) | Memorial Sloan Kettering Cancer Center | 2006-10-23 |
| Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin (NCT00397904) | Memorial Sloan Kettering Cancer Center | 2006-10-01 |
| Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma (NCT00503321) | Eastern Network of Cancer Immunological Therapy, Japan | 2006-10-01 |
| Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma (NCT00352833) | Neovii Biotech | 2006-07-01 |
| A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer (NCT02560974) | Hoffmann-La Roche | 2006-06-01 |
| Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer (NCT00387530) | University of California, San Diego | 2006-05-01 |
| S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery (NCT00335959) | SWOG Cancer Research Network | 2006-05-01 |
| Antiangiogenic Factors in Gastric Cancer (NCT00735566) | National Cancer Center, Korea | 2006-04-01 |
| Clinical Trial for Laparoscopic D2 Gastrectomy (NCT01163812) | National Cancer Center, Korea | 2006-04-01 |
| Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer (NCT00287768) | Japan Clinical Cancer Research Organization | 2006-03-01 |
| Clinical Trial of Chemosensitivity Test (NCT00287755) | Japan Clinical Cancer Research Organization | 2006-03-01 |
| RCT With Adjuvant Mistletoe Treatment in Gastric Cancer Patients (NCT01401075) | Abnoba Gmbh | 2006-03-01 |
| Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer (NCT00387348) | Massachusetts General Hospital | 2006-03-01 |
| Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients (NCT00738478) | Wakayama Medical University | 2006-02-01 |
| Comparison of Laparoscopic Versus Open Gastrectomy for Gastric Cancer: A Prospective Randomized Trial (NCT00452751) | National Cancer Center, Korea | 2006-02-01 |
| Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT00313599) | University of California, San Francisco | 2006-02-01 |
| Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking (NCT00365508) | Fox Chase Cancer Center | 2006-02-01 |
| A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer (NCT00533533) | Samsung Medical Center | 2006-01-01 |
| Bupropion in Helping Adults Stop Smoking (NCT00534001) | Roswell Park Cancer Institute | 2006-01-01 |
| Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric Carcinoma (NCT02002416) | Sun Yat-sen University | 2006-01-01 |
| Early Onset and Familial Gastric Cancer Registry (NCT00582257) | Memorial Sloan Kettering Cancer Center | 2005-12-13 |
| Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer (NCT00275951) | National Taiwan University Hospital | 2005-12-01 |
| Feasibility Trial of Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer (NCT01381913) | Kagawa University | 2005-10-01 |
| Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates (NCT00130936) | AHS Cancer Control Alberta | 2005-10-01 |
| ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer (NCT01041404) | Hoffmann-La Roche | 2005-09-01 |
| S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer (NCT00343668) | Korean Cancer Study Group | 2005-09-01 |
| Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors (NCT01172028) | University of Arizona | 2005-09-01 |
| Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer (NCT00215644) | Merck KGaA, Darmstadt, Germany | 2005-08-31 |
| Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer (NCT00202969) | Taiho Pharmaceutical Co., Ltd. | 2005-07-01 |
| Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer (NCT00130689) | Dana-Farber Cancer Institute | 2005-07-01 |
| Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer (NCT00857246) | NYU Langone Health | 2005-07-01 |
| Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery (NCT00448682) | University of Miami | 2005-06-01 |
| A Safety and Efficacy Study in Patients With Gastric Cancer (NCT00400179) | Taiho Oncology, Inc. | 2005-05-01 |
| Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor (NCT00711243) | Northwestern University | 2005-04-20 |
| Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma (NCT00183872) | University of Southern California | 2005-04-14 |
| Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer. (NCT00209729) | Hokkaido Gastrointestinal Cancer Study Group | 2005-04-01 |
| Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer (NCT00103103) | California Cancer Consortium | 2005-03-01 |
| Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer (NCT01147991) | Cancer Research UK | 2005-03-01 |
| Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK (NCT00216034) | Hokuriku-Kinki Immunochemotherapy Study Group | 2005-03-01 |
| A Study of E7070 in Patients With Gastric Cancer (NCT00165594) | Eisai Co., Ltd. | 2005-02-01 |
| Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer (NCT00354224) | Medical University of South Carolina | 2005-01-01 |
| Association and Mechanism Between Cyclooxygenase-2 and Interleukin-6 in Gastric Cancer (NCT00172627) | National Taiwan University Hospital | 2005-01-01 |
| Cyclooxygenase-2-Associated Factors and Gastric Carcinogenesis Mechanisms-Clinical Association and Genomic Investigation (NCT00172861) | National Taiwan University Hospital | 2005-01-01 |
| Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer (NCT01379482) | Uppsala University | 2005-01-01 |
| Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer (NCT00183898) | University of Southern California | 2004-12-28 |
| Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication (NCT01678027) | National Cancer Center, Korea | 2004-11-01 |
| Postoperative Enteral Immunonutrition in Gastric Cancer (NCT02647476) | Jagiellonian University | 2004-11-01 |
| Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial (NCT00278863) | Asan Medical Center | 2004-11-01 |
| Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer (NCT00217581) | Barbara Ann Karmanos Cancer Institute | 2004-10-01 |
| Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma (NCT00323830) | Samsung Medical Center | 2004-10-01 |
| Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer (NCT00439608) | Brown University | 2004-10-01 |
| Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer (NCT00486356) | University of Nebraska | 2004-10-01 |
| Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer (NCT00629863) | North Wales Organisation for Randomised Trials in Health | 2004-09-01 |
| Quality of Life Among Long-Term Survivors of Resected Gastric Cancer (NCT00598546) | Memorial Sloan Kettering Cancer Center | 2004-09-01 |
| S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer (NCT00134095) | Fukushima Medical University Hospital | 2004-09-01 |
| Avastin and Taxotere for Esophagogastric Cancer (NCT00137813) | Dana-Farber Cancer Institute | 2004-08-01 |
| Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer (NCT00210184) | Institut Bergonié | 2004-07-21 |
| Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients (NCT00447967) | Hellenic Oncology Research Group | 2004-07-01 |
| Standard and Immunostimulating Enteral Nutrition in Surgical Patients (NCT00576940) | Jagiellonian University | 2004-06-01 |
| Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer (NCT00155883) | National Taiwan University Hospital | 2004-06-01 |
| Doxil Topotecan Doublet Cancer Study (NCT00252889) | Christiana Care Health Services | 2004-05-01 |
| Chemoradiation-Induced Nausea and Emesis: Quality of Life (NCT00394602) | M.D. Anderson Cancer Center | 2004-04-07 |
| Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC. (NCT00209612) | Hokkaido Gastrointestinal Cancer Study Group | 2004-04-01 |
| S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer (NCT00182611) | Kyoto University | 2004-04-01 |
| A Recurrence Nomogram for Hepatoid Adenocarcinoma of the Stomach (NCT05274464) | Fujian Medical University | 2004-04-01 |
| Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors (NCT00096707) | Threshold Pharmaceuticals | 2004-02-01 |
| Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer (NCT00197431) | Hamamatsu University | 2004-01-01 |
| A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression (NCT02005484) | Hoffmann-La Roche | 2004-01-01 |
| Outcomes of Laparoscopic Gastrectomy (NCT04652986) | Juan Carlos Martín del Olmo | 2004-01-01 |
| Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer (NCT00209664) | Hokkaido Gastrointestinal Cancer Study Group | 2004-01-01 |
| Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) (NCT00525785) | M.D. Anderson Cancer Center | 2004-01-01 |
| Zinc Supplements in Lowering Cadmium Levels in Smokers (NCT00376987) | Wake Forest University Health Sciences | 2003-12-01 |
| Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma (NCT00183911) | University of Southern California | 2003-11-01 |
| Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancer (NCT00675194) | Johannes Gutenberg University Mainz | 2003-10-01 |
| Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer (NCT00072787) | Taiho Oncology, Inc. | 2003-10-01 |
| Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (NCT00074009) | Memorial Sloan Kettering Cancer Center | 2003-10-01 |
| Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction (NCT00054457) | Alliance for Clinical Trials in Oncology | 2003-09-01 |
| Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors (NCT00072332) | Memorial Sloan Kettering Cancer Center | 2003-08-01 |
| Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction (NCT00529412) | Nihon University | 2003-08-01 |
| Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas (NCT00215995) | H. Lee Moffitt Cancer Center and Research Institute | 2003-07-01 |
| Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer (NCT01002443) | National Cancer Center, Korea | 2003-07-01 |
| Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer (NCT00062257) | Cancer Therapeutics Research Group | 2003-06-01 |
| Clinical Study on Laparoscopic Gastrectomy for Early Gastric Cancer (COACT_0301) (NCT00546468) | National Cancer Center, Korea | 2003-06-01 |
| Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer (NCT00313872) | Samsung Medical Center | 2003-05-01 |
| The Effects of Sex and Age Differences on Gastric Cancer : a Retrospective Study (NCT04973631) | Seoul National University Bundang Hospital | 2003-05-01 |
| A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer (NCT02563054) | Hoffmann-La Roche | 2003-04-01 |
| S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer (NCT00088816) | Kyoto University | 2003-04-01 |
| Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer (NCT00154778) | National Taiwan University Hospital | 2003-03-01 |
| Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer (NCT06301464) | Seoul National University Bundang Hospital | 2003-03-01 |
| A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer (NCT00123318) | Trans Tasman Radiation Oncology Group | 2003-02-01 |
| Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer (NCT00052910) | Alliance for Clinical Trials in Oncology | 2002-12-01 |
| Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer (NCT00858338) | NYU Langone Health | 2002-12-01 |